BioNexus Gene Lab Corp

Bionexus Gene Lab Corporation (BGLC) is a healthcare company specializing in blood-based genomic screening (BGS). They utilize RNA analysis to predict the risk of developing certain diseases, including eight common cancers, two inflammatory diseases, and osteoarthritis, even before symptoms appear. This early detection allows individuals to take proactive steps to maintain their health and potentially prevent the onset of these diseases.

BGLC was founded by the late Professor Emeritus Dato Dr Liew Choong-Chin, a pioneer in the field of molecular medicine. The company is headquartered in Wyoming, USA, with its main testing center located in Malaysia, operated by its subsidiary, MRNA SCIENTIFIC SDN BHD. BGLC is committed to research and development, constantly refining their BGS technology and collaborating with leading researchers in the field.

BioNexus Gene Lab Corporation specializes in early disease detection through blood-based genomic screening. Their technology analyzes changes in RNA to predict predisposed diseases before symptoms appear, empowering individuals to take proactive measures for their health. The company utilizes proprietary software to generate predictive scores, providing reports that help identify and manage potential health risks.

BioNexus Gene Lab promotes a culture rooted in innovation and scientific advancement, driven by the pursuit of early disease detection through blood-based genomic screening. The company's commitment to research and development is evident in its close collaboration with academic institutions and its team of leading scientists, fostering a collaborative and intellectually stimulating environment.

BioNexus Gene Lab Corporation has a limited amount of information on their website regarding their approach to diversity, equity and inclusion. While they do not specifically state their commitment to these values, the company's Board Diversity Matrix does show that there are five directors and all are male. Therefore, the company can be said to lack diversity on its board, indicating a possible lack of commitment to inclusion.